BML Investment Partners, L.P. Sent A Letter To The Board Of Directors Of Forte Biosciences, Inc.

Paul,

Thanks for the reply.

I am not surprised that you and the Board have expressed confidence that Forte has the right strategy in place with FB-102. Yet the lack of even one insider purchase since the May 16th announcement detailing the plans to develop this compound makes us skeptical this is truly the case. As I’m sure you’re aware, Forte shares have…